-
Mashup Score: 5Neurobiological Correlates of Psilocybin Response in MDD - 1 year(s) ago
Transient functional brain changes with psilocybin therapy resemble the “brain reset” phenomenon and may serve as the putative predictors of psilocybin antidepressant response.
Source: Psychiatrist.comCategories: Latest Headlines, PsychiatryTweet
-
Mashup Score: 0
Lumateperone significantly improved depression symptoms, disease severity, and quality of life in patients with bipolar depression with mixed features.
Source: Psychiatrist.comCategories: Latest Headlines, PsychiatryTweet-
Lumateperone significantly improved depression symptoms, disease severity, and quality of life in patients with #BipolarDepression with mixed features. https://t.co/P8qPGLkbrv
-
-
Mashup Score: 1
School shootings and other forms of gun violence are having a negative impact on American children, warns a Nashville pediatrician.
Source: Psychiatrist.comCategories: Latest Headlines, PsychiatryTweet-
We spoke to a Nashville pediatrician about the impact of #gunviolence on an entire generation. https://t.co/itEczIUpRo via @everytown, @momsdemand, @kbgastineau
-
-
Mashup Score: 7
With its antisuicidal effect and low cost, lithium can be an effective alternative to other MDD augmentation strategies when antidepressants are not enough.
Source: Psychiatrist.comCategories: Latest Headlines, PsychiatryTweet-
With its antisuicidal effect and low cost, lithium can be an effective alternative to other MDD augmentation strategies. https://t.co/JzPuEfcK7C via @ASCPorg (Free access content)
-
-
Mashup Score: 2Emerging Treatment Approaches for Schizophrenia Show Promise - 1 year(s) ago
Leslie Citrome, MD, MPH discusses treatments for schizophrenia that will herald a new era in its management.
Source: Psychiatrist.comCategories: Latest Headlines, PsychiatryTweet-
Treatment for people with #schizophrenia is on the cusp of a new era -- more effective medication with fewer side effects. https://t.co/4xzjaMOQx5
-
-
Mashup Score: 0Doxepin-Associated Hypoglycemia in a Nondiabetic Patient - 1 year(s) ago
It is important for clinicians to be aware of the potential impact of antidepressants on glucose regulation.
Source: Psychiatrist.comCategories: Latest Headlines, PsychiatryTweet-
The potential impact of #antidepressants on glucose regulation. https://t.co/ZFBoSNuS6U
-
-
Mashup Score: 4Initiative to Improve Antipsychotic Metabolic Monitoring - 1 year(s) ago
Interprofessional monthly care conferences can improve coordination of care across mental health and primary care settings.
Source: Psychiatrist.comCategories: Latest Headlines, PsychiatryTweet-
Preparative and scheduled QI interventions provide powerful reminders of the SGA monitoring guidelines that improved the metabolic monitoring behaviors. https://t.co/9F9lYqtsXH
-
-
Mashup Score: 0
FDA’s groundbreaking guidance aims to advance and legitimize psychedelic drug research while promoting safety.
Source: Psychiatrist.comCategories: Latest Headlines, PsychiatryTweet-
The first ever draft guidance for researching psychedelic drugs in medicine emphasizes unique considerations for clinical trials and potential for abuse. See commentary. https://t.co/ba5IZSnTTx https://t.co/k7S81j5WLW
-
-
Mashup Score: 5Social Determinants of Health and Extended-Release Naltrexone - 1 year(s) ago
Patients with alcohol use disorder are at high risk of treatment nonadherence and readmission. While ER naltrexone can help prevent relapse for 28 days, they may face homelessness for several months.
Source: Psychiatrist.comCategories: Latest Headlines, PsychiatryTweet-
Administering ER naltrexone prior to discharge may protect patients with alcohol use disorder from relapsing and readmission. https://t.co/FfbThphMEK
-
-
Mashup Score: 1
ABSTRACT Objective: To test vitamin D3 and omega-3 fatty acids (omega-3s) for late-life depression prevention under the National Academy of Medicine framework for indicated (targeting subthreshold depression) and selective (targeting presence of high-risk factors) prevention. Methods: The VITamin D and OmegA-3 TriaL (VITAL) is a 2 í 2 factorial trial of vitamin D3 (2,000 IU/d) and/or omega-3s (1…
Source: Psychiatrist.comCategories: Latest Headlines, PsychiatryTweet-
Case Report: accelerated-onset diabetes insipidus secondary to lithium use. https://t.co/53JNCdl2R5
-
Transient functional brain changes with #psilocybin therapy resemble the “brain reset” phenomenon and may serve as the putative predictors of its #antidepressant response. https://t.co/YS4KQivlUR